Biopharmaceutical stocks are in focus on Monday after Bristol-Myers Squibb (BMY) announced an $11 billion partnership with ...

According to the Korea Health Industry Promotion Agency on the 4th, pharmaceutical exports in the first quarter reached $2.56 ...

The Inducement Grants have been granted pursuant to the Company's 2023 Inducement Plan (the "Plan”). The Inducement Grants ...

Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO) (“Rakovina” or the “Company”), a biopharmaceutical company advancing innovative cancer therapies through artificial intelligence ...

This case involves an appeal from Regeneron Pharmaceuticals, Inc.’s (Regeneron) efforts to prevent defendants from marketing biosimilar versions ...

At the ASMS Conference in Baltimore, the company highlighted several new products tailored to a range of application areas, ...

The continuous, solid-phase system achieved a refolding yield of approximately 100% by gradually pumping lysozyme through the ...